ECTRIMS 2022 (2) – Pregnancy and Breastfeeding
In view of practically relevant results from this year’s ECTRIMS meeting, I would like to emphasize studies on pregnancy and breastfeeding. B-cell-depleting therapies such as ocrelizumab and ofatumumab are often used in women of childbearing
Continue reading